Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Longrange 50 mg Solution (Extended Release) is a Health Canada–registered veterinary drug (DIN 02450798) held by Boehringer Ingelheim Animal Health Canada Inc., containing Eprinomectin. Health Canada lists its status as Marketed (status date 10 Jun 2020). Nexara Health has matched 17 registrations of Eprinomectin across 5 other regulated markets.

Health Canada registration

DIN02450798
Brand nameLongrange
Active ingredientEprinomectin
Strength50 mg
Dosage formSolution (Extended Release)
RouteSubcutaneous
CompanyBoehringer Ingelheim Animal Health Canada Inc.
StatusMarketed — 10 Jun 2020
ClassVeterinary
ATC
AHFS
Regulator recordHealth Canada DPD entry · Product monograph

Eprinomectin registered in other markets

17 registrations of the same molecule in 5 national registries outside Canada (first 16 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
DenmarkEprecis Vet.Ceva Sante Animale20 mg/mlinjektionsvæske, opløsningDecentral procedureLaegemiddelstyrelsen
DenmarkEprinex Vet.Boehringer Ingelheim Animal Health Nordics A/S5 mg/mlpour-on, opløsningMRPLaegemiddelstyrelsen
DenmarkNeoprinil pour-onVirbac S.A.5 mg/mlpour-on, opløsningDecentral procedureLaegemiddelstyrelsen
DenmarkPereprinHuvepharma5 mg/mlpour-on, opløsningDecentral procedureLaegemiddelstyrelsen
DenmarkZepromecChanelle Pharmaceuticals Manufacturing Limited5 mg/mlpour-on, opløsningMRPLaegemiddelstyrelsen
European Union (EMA)LongrangeMerialRefusedEMA centrally authorised
MalaysiaEPRECIS 20 mg/ml solution for injectionCeva Animal Health Malaysia Sdn. Bhd.VeterinaryPRODUCT APPROVEDNPRA
PolandElivecIndustrial Veterinaria, S.A.5 mg/mlRoztwór do polewaniaBezterminoweURPL RPL
PolandEprecisCeva Animal Health Polska Sp. z o.o.5 mg/mlRoztwór do polewaniaBezterminoweURPL RPL
PolandEprecisCeva Animal Health Polska Sp. z o.o.20 mg/mlRoztwór do wstrzykiwańBezterminoweURPL RPL
PolandEprinex MultiBoehringer Ingelheim Animal Health France SCS5 mg/mlRoztwór do polewaniaBezterminoweURPL RPL
PolandEprivalanBoehringer Ingelheim Animal Health France SCS5,0 mg/mlRoztwór do polewania2021-09-24URPL RPL
PolandEprizeroNorbrook Laboratories (Ireland) Limited5 mg/mlRoztwór do polewaniaBezterminoweURPL RPL
PolandEpromecChanelle Pharmaceuticals Manufacturing Ltd.5 mg/mlRoztwór do polewaniaBezterminoweURPL RPL
PolandNeoprinil Pour-OnVirbac S.A.5 mg/mlRoztwór do polewaniaBezterminoweURPL RPL
United StatesEprinomectinZhejiang Hisun Pharmaceutical Co., Ltd.PowderFDA NDC

See every manufacturer of Eprinomectin worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Longrange (DIN 02450798) marketed in Canada?

Yes. Health Canada lists DIN 02450798 as Marketed as of 10 Jun 2020.

Who holds the Canadian licence for this product?

Boehringer Ingelheim Animal Health Canada Inc. is the company of record in the Health Canada Drug Product Database.

Is Eprinomectin registered outside Canada?

Yes — Nexara Health has matched 17 registrations in 5 other markets (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02450798, status date 2020-06-10; national medicine registries: EMA centrally authorised, FDA NDC, Laegemiddelstyrelsen, NPRA, URPL RPL. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02450798, status date 2020-06-10; national medicine registries: EMA centrally authorised, FDA NDC, Laegemiddelstyrelsen, NPRA, URPL RPL.

Health Canada Drug Product Database (DPD), DIN 02450798, status date 2020-06-10; national medicine registries: EMA centrally authorised, FDA NDC, Laegemiddelstyrelsen, NPRA, URPL RPL. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.